BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 8270860)

  • 1. Reduced life span of anergic self-reactive B cells in a double-transgenic model.
    Fulcher DA; Basten A
    J Exp Med; 1994 Jan; 179(1):125-34. PubMed ID: 8270860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.
    Fulcher DA; Lyons AB; Korn SL; Cook MC; Koleda C; Parish C; Fazekas de St Groth B; Basten A
    J Exp Med; 1996 May; 183(5):2313-28. PubMed ID: 8642340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whither the anergic B-cell?
    Fulcher DA; Basten A
    Autoimmunity; 1994; 19(2):135-40. PubMed ID: 7772703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anergic B cells constitutively present self antigen: enhanced immunoglobulin receptor-mediated presentation of antigenic determinants by B cells is hierarchical.
    Kanost D; McCluskey J
    Eur J Immunol; 1994 May; 24(5):1186-93. PubMed ID: 7514133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.
    Phan TG; Amesbury M; Gardam S; Crosbie J; Hasbold J; Hodgkin PD; Basten A; Brink R
    J Exp Med; 2003 Apr; 197(7):845-60. PubMed ID: 12668643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo survival of autoreactive B cells: characterization of long-lived B cells.
    Morris SC; Moroldo M; Giannini EH; Orekhova T; Finkelman FD
    J Immunol; 2000 Mar; 164(6):3035-46. PubMed ID: 10706692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue of self-reactive B cells by provision of T cell help in vivo.
    Cook MC; Basten A; Fazekas de St Groth B
    Eur J Immunol; 1998 Aug; 28(8):2549-58. PubMed ID: 9710232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breakdown of tolerance to a neo-self antigen in double transgenic mice in which B cells present the antigen.
    de Vos AF; Fukushima A; Lobanoff MC; Vistica BP; Lai JC; Grivel JC; Wawrousek EF; Whitcup SM; Gery I
    J Immunol; 2000 May; 164(9):4594-600. PubMed ID: 10779762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin M and D antigen receptors are both capable of mediating B lymphocyte activation, deletion, or anergy after interaction with specific antigen.
    Brink R; Goodnow CC; Crosbie J; Adams E; Eris J; Mason DY; Hartley SB; Basten A
    J Exp Med; 1992 Oct; 176(4):991-1005. PubMed ID: 1402669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outer periarteriolar lymphoid sheath arrest and subsequent differentiation of both naive and tolerant immunoglobulin transgenic B cells is determined by B cell receptor occupancy.
    Cook MC; Basten A; Fazekas de St Groth B
    J Exp Med; 1997 Aug; 186(5):631-43. PubMed ID: 9271579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PECAM-1-regulated signalling thresholds control tolerance in anergic transgenic B-cells.
    Wong MX; Hayball JD; Jackson DE
    Mol Immunol; 2008 Mar; 45(6):1767-81. PubMed ID: 17977600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
    Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
    J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reactive B lymphocytes overexpressing Bcl-xL escape negative selection and are tolerized by clonal anergy and receptor editing.
    Fang W; Weintraub BC; Dunlap B; Garside P; Pape KA; Jenkins MK; Goodnow CC; Mueller DL; Behrens TW
    Immunity; 1998 Jul; 9(1):35-45. PubMed ID: 9697834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NFAT1 in B cell self-tolerance.
    Barrington RA; Borde M; Rao A; Carroll MC
    J Immunol; 2006 Aug; 177(3):1510-5. PubMed ID: 16849457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ig light chain receptor editing in anergic B cells.
    Tze LE; Baness EA; Hippen KL; Behrens TW
    J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intact B cell tolerance in the absence of the first component of the classical complement pathway.
    Cutler AJ; Cornall RJ; Ferry H; Manderson AP; Botto M; Walport MJ
    Eur J Immunol; 2001 Jul; 31(7):2087-93. PubMed ID: 11449362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anergic self-reactive B cells present self antigen and respond normally to CD40-dependent T-cell signals but are defective in antigen-receptor-mediated functions.
    Eris JM; Basten A; Brink R; Doherty K; Kehry MR; Hodgkin PD
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4392-6. PubMed ID: 7514304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production.
    Morris SC; Dragula NL; Finkelman FD
    J Immunol; 2002 Aug; 169(4):1696-704. PubMed ID: 12165489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced responsiveness to T-cell help causes loss of B-lymphocyte tolerance to a β-cell neo-self-antigen in type 1 diabetes prone NOD mice.
    Cox SL; Stolp J; Hallahan NL; Counotte J; Zhang W; Serreze DV; Basten A; Silveira PA
    Eur J Immunol; 2010 Dec; 40(12):3413-25. PubMed ID: 21108464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells.
    Cooke MP; Heath AW; Shokat KM; Zeng Y; Finkelman FD; Linsley PS; Howard M; Goodnow CC
    J Exp Med; 1994 Feb; 179(2):425-38. PubMed ID: 8294858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.